Harvard spin-off closes $5M seed round in pursuit of a new treatment modality: therapeutic mitochondria transfer
Fresh capital to be employed for productization, including a first application in rejuvenation
10-Feb-2021 -
cellvie Inc., the leader in Therapeutic Mitochondria Transfer (TMT) and a Harvard University spin-off, closes a $5M round to advance its product pipeline, including a first application in rejuvenation.
Mitochondria are intimately tied to the origin of complex life, the energy of the young and the ...
ageing
financing
ischemia reperfusion
+1